DNP 672 Module 4 Classes of Mood Stabilizers Discussion Example

Reviewed by Ingrid Vasterling, MSN, RN Arizona State University Updated October 2026

This DNP 672 Module 4 sample is discussion board 6 in Psychopharmacology Across the Lifespan, one of the psychiatric NP track's pharmacology courses in ASU's DNP. ASU DNP 672 asks students, during the bipolar disorder week, how the classes of mood stabilizers differ. The composite student compares lithium, the anticonvulsants valproate, carbamazepine and lamotrigine, and the atypical antipsychotics by which phase of illness they treat, what they require for monitoring and their main risks. She cites evidence on lithium and suicide, a trial comparing lithium with valproate, international guideline choices and pregnancy cautions, and replies to a classmate about lamotrigine rash. No doses are given.

CourseDNP 672 Psychopharmacology Across the Lifespan
ModuleModule 4
Paper typeDiscussion board post and reply
LengthAbout 391 words
FormatDiscussion post with APA 7 citations
SchoolArizona State University
ProgramDoctor of Nursing Practice
UpdatedOctober 2026

Free sample paper for DNP 672 Module 4

1

DB 6: Lithium, Anticonvulsants and Antipsychotics as Mood Stabilizers

Up, Down or Both: How the Classes of Mood Stabilizers Differ in Bipolar Disorder

Initial Post

The key difference: which pole. Mood stabilizers differ most in whether they treat mania, depression or both, and in how well they prevent relapse. International guidelines list lithium as a first-line maintenance treatment for bipolar I disorder, along with options such as quetiapine, valproate and, mainly for preventing depression, lamotrigine (Yatham et al., 2018).

Lithium. Lithium treats mania and prevents both manic and depressive relapse. It has a unique benefit: in a meta-analysis of 48 randomized trials, lithium reduced suicides compared with placebo (odds ratio 0.13) and deaths from any cause (Cipriani et al., 2013). Its drawbacks are a narrow therapeutic range, the need for blood level monitoring, effects on the kidneys and thyroid and toxicity when combined with dehydration, NSAIDs or certain diuretics.

Valproate. Valproate works well for acute mania, including mixed features. In the BALANCE trial of people with bipolar I disorder, lithium alone was more likely than valproate alone to prevent relapse over up to two years (hazard ratio 0.71), and the combination was better than valproate alone (BALANCE Investigators and Collaborators, 2010). Valproate can cause weight gain, tremor and liver toxicity and is highly teratogenic, so it should be avoided in people who could become pregnant unless no alternative exists.

Carbamazepine. Carbamazepine treats mania but induces liver enzymes, lowering levels of many drugs, including hormonal contraceptives. It can cause serious rash, especially in people of Asian ancestry with the HLA-B*1502 allele, and rare blood disorders.

Lamotrigine. Lamotrigine helps prevent bipolar depression but does little for mania. Its dose has to climb slowly over weeks, because fast titration raises the chance of a dangerous rash such as Stevens-Johnson syndrome.

Atypical antipsychotics. Several, such as quetiapine, aripiprazole and olanzapine, treat acute mania, and some, such as quetiapine and lurasidone, treat bipolar depression. Their main costs are weight gain and metabolic effects.

How I would choose. I match the drug to the phase that dominates the patient's illness, the need for suicide prevention, pregnancy potential, medical problems and the patient's willingness to have regular blood tests.

What this page is doingOrganizing the comparison around which phase each class treats, then adding one strong study for lithium and valproate, turns a list of drugs into the decision framework the prompt is after.
2

Reply to a Classmate (Lamotrigine Rash)

You asked what to do if a patient on lamotrigine develops a rash. Stop the drug and evaluate promptly; after a pause of several days, restarting requires the full slow titration again.

References

BALANCE Investigators and Collaborators. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. The Lancet, 375(9712), 385-395. https://doi.org/10.1016/S0140-6736(09)61828-6

Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013). Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. BMJ, 346, Article f3646. https://doi.org/10.1136/bmj.f3646

Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R. V., Ravindran, A., O'Donovan, C., McIntosh, D., Lam, R. W., Vazquez, G., Kapczinski, F., ... Berk, M. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97-170. https://doi.org/10.1111/bdi.12609

What the DNP 672 Module 4 instructions ask for

The posted syllabus covers bipolar disorder in this week, with chapters from the course texts, and sets discussion board 6: describe the differences in the different classes of mood stabilizers. Posts are graded with the same weekly rubric as the other boards, and at least one of the two posts should bring current evidence. Plan to compare lithium, the anticonvulsants and the atypical antipsychotics on which phase of bipolar illness they treat or prevent, their monitoring requirements, their main risks and special considerations such as pregnancy and drug interactions. Because many students will cover the same drugs, organizing your comparison around clinical decisions, rather than drug by drug, makes it more useful.

How the DNP 672 Module 4 example is put together

The post opens with the main difference among mood stabilizers, which phase they treat, and cites international guideline first-line choices. Short sections then cover lithium with suicide-prevention evidence, valproate with a relapse-prevention trial and pregnancy caution, carbamazepine with interactions and rash risk, lamotrigine with its depression focus and titration, and atypical antipsychotics with metabolic costs. A closing paragraph lists how the writer chooses among them. A short reply addresses lamotrigine rash. Three sources support it: a meta-analysis, a randomized trial and the CANMAT and ISBD guidelines, each available by DOI. Each section is short and follows the same order, use, evidence and risk, so classmates can compare drugs at a glance and see the main reason to choose or avoid each one in practice.

DNP 672 Module 4 rubric: what earns full marks

Faculty will probably look for accurate distinctions between classes, especially which phase each treats, correct monitoring and safety information, current evidence, attention to special populations, such as people who could become pregnant, and clear clinical reasoning. Posts earn more when they explain why a difference matters, for example lithium's effect on suicide or lamotrigine's lack of antimanic effect. Citing guidelines and a key trial shows evidence-based thinking. Replies that address practical safety questions, such as rash or drug interactions, add depth to the discussion. Faculty may also credit posts that mention what patients find hard about each drug, such as regular lithium blood tests, since adherence shapes outcomes as much as efficacy.

DNP 672 Module 4 help from the desk

One common slip is treating all mood stabilizers as interchangeable. Explain which phase each treats best. Another is leaving out pregnancy and interaction risks, which are central to safe prescribing. Verify monitoring requirements against a current reference. If you want help preparing your own mood stabilizer comparison, tell the desk which drugs your faculty emphasized. Keep doses and target levels out unless asked. Add a patient example from your practicum in replies. Build your comparison around a real patient decision, such as a young woman with bipolar depression who plans a pregnancy, and show which classes fit and which do not.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

Request this one custom, free All DNP 672 module samples

More DNP 672 and Doctor of Nursing Practice sample papers

DNP 672 Module 4 questions, answered

Where can I find a free DNP 672 Module 4 sample paper?

The paper above is a whole DNP 672 board 6 sample comparing lithium, anticonvulsants and atypical antipsychotics as mood stabilizers.

Why is lithium still used for bipolar disorder?

Lithium prevents manic and depressive relapse and is the only mood stabilizer with strong evidence for reducing suicide.

Which mood stabilizer works best for bipolar depression?

Lamotrigine helps prevent bipolar depression, and some atypical antipsychotics treat it, while lithium helps both poles.

Why is valproate avoided in people who could become pregnant?

Valproate is highly teratogenic, so it should be avoided unless no alternative exists.

What does DNP 672 discussion board 6 ask?

To describe the differences among the classes of mood stabilizers in the bipolar disorder week.